Loading...
Direct inhibitors of InhA active against Mycobacterium tuberculosis
New chemotherapeutic agents are urgently required to combat the global spread of multi-drug resistant tuberculosis (MDR-TB). The mycobacterial enoyl reductase, InhA, is one of the few clinically-validated targets in tuberculosis drug discovery. Here, we report the identification of a new class of di...
Na minha lista:
| Udgivet i: | Sci Transl Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4383039/ https://ncbi.nlm.nih.gov/pubmed/25568071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3010597 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|